Aspirin resistance among long-term aspirin users after carotid endarterectomy and controls: Flow cytometric measurement of aspirin-induced platelet inhibition

Journal of Vascular Surgery

Volumn 45, Issue 6, 2007, Pages 1142-1147

  Assadian, Afshin ^a   Lax, Jaqueline ^b   Meixner Loicht, Ursula ^a   Hagmüller, Georg W ^a   Bayer, Peter Michael ^b   Hübl, Wolfgang ^b  

^a Wilhelminenspital Vienna ^*  (Austria)

^b WILHELMINEN HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ARACHIDONIC ACID; COLLAGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; PADGEM PROTEIN; PHOSPHATE BUFFERED SALINE; PHYCOERYTHRIN; PROSTAGLANDIN SYNTHASE; PROTEIN ANTIBODY; THROMBOASS; UNCLASSIFIED DRUG;

AGED; ANALYZER; ANTIGEN EXPRESSION; ARTICLE; CAROTID ARTERY THROMBOSIS; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA; TREATMENT DURATION;

AGED; ARACHIDONIC ACID; ASPIRIN; BLOOD PLATELETS; CAROTID STENOSIS; CASE-CONTROL STUDIES; CYCLOOXYGENASE INHIBITORS; DRUG RESISTANCE; ENDARTERECTOMY, CAROTID; FEMALE; FIBRINOLYTIC AGENTS; FLOW CYTOMETRY; HUMANS; MALE; P-SELECTIN; PLATELET FUNCTION TESTS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SEVERITY OF ILLNESS INDEX;

EID: 34249290080     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.01.064     Document Type: Article

References (22)

1. Roth G.J., and Majerus P.W. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J Clin Invest 56 (1975) 624-632
2. Roth G.J., Stanford N., and Majerus P.W. Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci U S A 72 (1975) 3073-3076
3. Patrono C., Coller B., FitzGerald G.A., Hirsh J., and Roth G. Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 234S-264S
4. Patrono C., Garcia Rodriguez L.A., Landolfi R., and Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 353 (2005) 2373-2383
5. Hankey G.J., and Eikelboom J.W. Aspirin resistance. Lancet 367 (2006) 606-617
6. Patrono C. Aspirin resistance: definition, mechanisms and clinical read-outs. J Thromb Haemost 1 (2003) 1710-1713
7. Michelson A.D., Cattaneo M., Eikelboom J.W., Gurbel P., Kottke-Marchant K., Kunicki T.J., et al. Aspirin resistance: position paper of the Working Group on Aspirin Resistance. J Thromb Haemost 3 (2005) 1309-1311
8. Szczeklik A., Musial J., Undas A., Sanak M., and Nizankowski R. Aspirin resistance. Pharmacol Rep 57 suppl (2005) 33-41
9. Payne D.A., Jones C.I., Hayes P.D., Webster S.E., Naylor A.R., and Goodall A.H. Platelet inhibition by aspirin is diminished in patients during carotid surgery: a form of transient aspirin resistance?. Thromb Haemost 92 (2004) 89-96
10. Webster S.E., Payne D.A., Jones C.I., Hayes P.D., Bell P.R.F., Goodall A.H., et al. Anti-platelet effect of aspirin is substantially reduced after administration of heparin during carotid endarterectomy. J Vasc Surg 40 (2004) 463-468
11. Harrison P., Segal H., Blasbery K., Furtado C., Silver L., and Rothwell P.M. Screening for aspirin responsiveness after transient ischemic attack and stroke. Comparison of 2 point-of-care platelet function tests with optical aggregometry. Stroke 36 (2005) 1001-1005
12. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high grade stenosis. N Engl J Med 325 (1991) 444-445
13. Hillarp A., Lethagen S., and Mattiasson I. Aspirin resistance is not a common biochemical phenotype explained by unblocked cyclooxygenase-1 activity. J Thromb Haemost 1 (2003) 196-197
14. Sambola A., Heras M., Escolar G., Lozano M., Pino M., Martorell T., et al. The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin. Platelets 15 (2004) 439-446
15. Alberts M.J., Bergman D.L., Molner E., Jovanovic B.D., Ushiwata I., and Teruya J. Antiplatelet effect of aspirin in patients with cerebrovascular disease. Stroke 35 (2004) 175-178
16. Ohmori T., Yatomi Y., Nonaka T., Kobayashi Y., Madoiwa S., Mimuro J., et al. Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients. J Thromb Haemost 4 (2006) 1271-1278
17. Mitchell J.A., and Warmenr T.D. Cox isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs. Nat Rev 5 (2006) 75-85
18. Schmitz G., Rothe G., Ruf A., Barlage S., Tschope D., Clemetson K.J., et al. European Working Group on Clinical Cell Analysis: consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost 79 (1998) 885-896
19. Panzer S., Hocker L., and Koren D. Agonists-induced platelet activation varies considerably in healthy male individuals: studies by flow cytometry. Ann Hematol 85 (2006) 121-125
20. Diener H.C., Bogousslavsky J., Brass L.M., Cimminiello C., Csiba L., Kaste M., et al., MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364 (2004) 331-337
21. Bhatt D.L., Fox K.A.A., Hacke W., Berger P.B., Black H.R., Boden W.E., et al., CHARISMA Investigators. Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events. N Engl J Med 354 (2006) 1706-1717
22. Frelinger III A.L., Furman M.I., Linden M.D., Li Y., Fox M.L., Barnar M.R., et al. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independant pathway. A 700-patient study of aspirin resistance. Circulation 113 (2006) 2888-2896